Cialis Related Published Studies
Well-designed clinical trials related to Cialis (Tadalafil)
Effect of tadalafil on blood flow, pain, and function in chronic cold Complex Regional Pain Syndrome: a randomized controlled trial. [2008.10.20]
Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study. [2008.10]
Investigating women's preference for sildenafil or tadalafil use by their partners with erectile dysfunction: the partners' preference study. [2008.05]
Effect of tadalafil on anaerobic performance indices in healthy athletes. [2008.02]
Inhibition of phosphodiesterase type 5 with tadalafil is associated to an improved activity of circulating angiogenic cells in men with cardiovascular risk factors and erectile dysfunction. [2008.01]
Tadalafil and fluoxetine in premature ejaculation: prospective, randomized, double-blind, placebo-controlled study. [2008]
Tadalafil (Cialis) and erectile dysfunction after radiotherapy for prostate cancer: an open-label extension of a blinded trial. [2007.12]
Efficacy and Safety of Tadalafil in Men With Erectile Dysfunction Following Spinal Cord Injury. [2007.09.10]
Evaluation of an alternative dosing regimen with tadalafil, three times per week, for men with erectile dysfunction: SURE study in Italy. [2007.05]
A comparison of the efficacy and tolerability of tadalafil 10 mg and 20 mg in Japanese patients with severe erectile dysfunction. [2007.05]
Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia. [2007.04]
The effects of tadalafil on cold-induced vasoconstriction in patients with Raynaud's phenomenon. [2007.04]
Efficacy and safety of on demand tadalafil in the treatment of East and Southeast Asian men with erectile dysfunction: a randomized double-blind, parallel, placebo-controlled clinical study. [2006.11]
Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial. [2006.10.03]
A randomized, double-blind, placebo-controlled, cross-over study to assess the efficacy of tadalafil (Cialis) in the treatment of erectile dysfunction following three-dimensional conformal external-beam radiotherapy for prostatic carcinoma. [2006.10.01]
Through the eyes of women: the partners' perspective on tadalafil. [2006.09]
Evaluation of the Efficacy and Safety of Once-a-Day Dosing of Tadalafil 5mg and 10mg in the Treatment of Erectile Dysfunction: Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. [2006.08]
Psychosocial outcomes and drug attributes affecting treatment choice in men receiving sildenafil citrate and tadalafil for the treatment of erectile dysfunction: results of a multicenter, randomized, open-label, crossover study. [2006.07]
Efficacy and safety of on-demand tadalafil for the treatment of erectile dysfunction in South-East Asian men. [2006.06]
Hemodynamic interaction study between the alpha1-blocker alfuzosin and the phosphodiesterase-5 inhibitor tadalafil in middle-aged healthy male subjects. [2006.06]
Efficacy and safety of two dosing regimens of tadalafil and patterns of sexual activity in men with diabetes mellitus and erectile dysfunction: Scheduled use vs. on-demand regimen evaluation (SURE) study in 14 European countries. [2006.05]
Tolerance to the therapeutic effect of tadalafil does not occur during 6 months of treatment: A randomized, double-blind, placebo-controlled study in men with erectile dysfunction. [2006.05]
Testosterone and erectile function in hypogonadal men unresponsive to tadalafil: results from an open-label uncontrolled study. [2006.04]
[Tadalafil vs sildenafil patient preference in Spanish men with erectile dysfunction: results from an International Multicentric Study] [2006.01]
An open-label, multicentre, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in men naive to phosphodiesterase 5 inhibitor therapy. [2005.12]
Efficacy and safety of oral tadalafil in the treatment of men in Canada with erectile dysfunction: a randomized, double-blind, parallel, placebo-controlled clinical trial. [2005.09]
Efficacy of tadalafil in the treatment of erectile dysfunction in hypertensive men on concomitant thiazide diuretic therapy. [2005.09]
The combined use of ibutilide as an active control with intensive electrocardiographic sampling and signal averaging as a sensitive method to assess the effects of tadalafil on the human QT interval. [2005.08.16]
An evaluation of an alternative dosing regimen with tadalafil, 3 times/week, for men with erectile dysfunction: SURE study in 14 European countries. [2005.06]
Tadalafil improved erectile function at twenty-four and thirty-six hours after dosing in men with erectile dysfunction: US trial. [2005.05]
A 6-month study of the efficacy and safety of tadalafil in the treatment of erectile dysfunction: a randomised, double-blind, parallel-group, placebo-controlled study in Australian men. [2005.02]
Efficacy, safety, and treatment satisfaction of tadalafil versus placebo in patients with erectile dysfunction evaluated at tertiary-care academic centers. [2005.02]
Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk. [2005.02]
Evaluation of sexual activity in patients treated with tadalafil: a randomized prospective placebo-controlled trial. [2005.01]
Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trials. [2004.11]
Interaction between the phosphodiesterase 5 inhibitor, tadalafil and 2 alpha-blockers, doxazosin and tamsulosin in healthy normotensive men. [2004.11]
Time/duration effectiveness of sildenafil versus tadalafil in the treatment of erectile dysfunction in male spinal cord-injured patients. [2004.11]
Integrated analysis examining first-dose success, success by dose, and maintenance of success among men taking tadalafil for erectile dysfunction. [2004.10]
Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction. [2004.10]
Efficacy and safety of on-demand oral tadalafil in the treatment of men with erectile dysfunction in taiwan: a randomized, double-blind, parallel, placebo-controlled clinical study. [2004.09]
Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial. [2004.09]
Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction. [2004.09]
Population dose-response model for tadalafil in the treatment of male erectile dysfunction. [2004.08]
The efficacy and safety of tadalafil in United States and Puerto Rican men with erectile dysfunction. [2004.08]
A multicenter, randomized, double-blind, crossover study to evaluate patient preference between tadalafil and sildenafil. [2004.04]
Time course of the interaction between tadalafil and nitrates. [2003.11.19]
A multicenter, randomized, double-blind, crossover study of patient preference for tadalafil 20 mg or sildenafil citrate 50 mg during initiation of treatment for erectile dysfunction. [2003.11]
Tadalafil has no detrimental effect on human spermatogenesis or reproductive hormones. [2003.09]
Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial. [2003.07]
Effects of tadalafil on erectile dysfunction in men with diabetes. [2002.12]
Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. [2002.10]
On-demand IC351 (Cialis) enhances erectile function in patients with erectile dysfunction. [2001.02]
Well-designed clinical trials possibly related to Cialis (Tadalafil)
Expression of the PDE5 enzyme on human retinal tissue: new aspects of PDE5 inhibitors ocular side effects. [2008.01]
Acute changes in pulmonary artery pressures due to exercise and exposure to high altitude do not cause left ventricular diastolic dysfunction. [2007.08]
Effects of high altitude exposure on cerebral hemodynamics in normal subjects. [2005.03]
Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study. [2004.10.06]
Other research related to Cialis (Tadalafil)
Comparative efficacy assessment of tamsulosin vs. tamsulosin plus tadalafil in the treatment of LUTS/BPH. Pilot study. [2008.09]
The type 5 phosphodiesterase inhibitor tadalafil influences salivary cortisol, testosterone, and dehydroepiandrosterone sulphate responses to maximal exercise in healthy men. [2008.09]
Efficacy and safety of tadalafil in the treatment of Latin American men with erectile dysfunction: results of integrated analyses. [2008.08]
Comparative Efficacy Assessment of Tamsulosin vs. Tamsulosin Plus Tadalafil in the Treatment of LUTS/BPH. Pilot Study. [2008.07.14]
Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice. [2008.07]
Psychosocial impact and effectiveness of tadalafil among treatment-naive and previously-treated men with erectile dysfunction in Saudi Arabia and other Gulf-region countries. [2008.07]
Vardenafil, but not sildenafil or tadalafil, has calcium-channel blocking activity in rabbit isolated pulmonary artery and human washed platelets. [2008.06]
Alternate-day tadalafil in the management of honeymoon impotence. [2008.06]
Efficacy and Safety of Tadalafil in the Treatment of Latin American men with Erectile Dysfunction: Results of Integrated Analyses. [2008.05.05]
Pharmacokinetic interaction between tadalafil and bosentan in healthy male subjects. [2008.05]
The effects of tadalafil on axial-pattern skin flap survival in rats. [2008.05]
Tadalafil improves oxygenation in a model of newborn pulmonary hypertension. [2008.05]
An evaluation of semen characteristics in men 45 years of age or older after daily dosing with tadalafil 20mg: results of a multicenter, randomized, double-blind, placebo-controlled, 9-month study. [2008.05]
Combination of alfuzosin and tadalafil exerts in vitro an additive relaxant effect on human corpus cavernosum. [2008.04]
[Evaluation of tadalafil for the treatment of erectile dysfunction] [2008.04]
Tadalafil is efficacious and well tolerated in the treatment of erectile dysfunction (ED) in men over 65 years of age: results from Multiple Observations in Men with ED in National Tadalafil Study in the United States. [2008.03]
Pharmacokinetic Interaction Between Tadalafil and Bosentan in Healthy Male Subjects. [2008.02.27]
Investigating Women's Preference for Sildenafil or Tadalafil Use by Their Partners with Erectile Dysfunction: The Partners' Preference Study. [2008.02.25]
Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction. [2008.02]
cDNA microarray analysis of differentially expressed genes in penile tissue after treatment with tadalafil. [2008.02]
Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection. [2008.01]
The cardiovascular safety of tadalafil. [2008.01]
Efficacy and safety of tadalafil in men with erectile dysfunction following spinal cord injury. [2007.11]
Treatment preferences in men with erectile dysfunction: an open label study in Korean men switching from sildenafil citrate to tadalafil. [2007.11]
An Evaluation of Semen Characteristics in Men 45 Years of Age or Older after Daily Dosing with Tadalafil 20mg: Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled, 9-Month Study. [2007.10.05]
Hemodynamic interaction between a daily dosed phosphodiesterase 5 inhibitor, tadalafil, and the alpha-adrenergic blockers, doxazosin and tamsulosin, in middle-aged healthy male subjects. [2007.10]
Alterations in sperm motility after acute oral administration of sildenafil or tadalafil in young, infertile men. [2007.10]
Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naive to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study. [2007.07]
Alterations in sperm motility after acute oral administration of sildenafil or tadalafil in young, infertile men. [2007.06.01]
Tadalafil population pharmacokinetics in patients with erectile dysfunction. [2007.06]
Effect of tadalafil on erectile dysfunction in male patients with diabetes mellitus. [2007.06]
[Efficacy of tadalafil for erectile dysfunction: an updated review] [2007.06]
Do vardenafil and tadalafil have advantages over sildenafil in the treatment of erectile dysfunction? [2007.05]
Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: a pilot study. [2007.03]
Use of tadalafil for treating pulmonary arterial hypertension secondary to chronic obstructive pulmonary disease. [2007.03]
[Advances in the studies on the safety of tadalafil in treating erectile dysfunction] [2007.03]
An observational cohort study investigating the cardiovascular safety of tadalafil when prescribed in primary care in England: mortality due to ischaemic heart disease. [2007.02]
Tadalafil for treatment of erectile dysfunction in men on antidepressants. [2007.02]
Tadalafil as an in vitro sperm motility stimulant. [2007.02]
Therapeutic effectiveness and patient satisfaction after 6 months of treatment with tadalafil, sildenafil, and vardenafil: results from the erectile dysfunction observational study (EDOS). [2007.02]
Efficacy and Safety of Tadalafil in Men with Erectile Dysfunction with a High Prevalence of Comorbid Conditions: Results from MOMENTUS: Multiple Observations in Men with Erectile Dysfunction in National Tadalafil Study in the US. [2007.01]
The influence of age on treatment outcomes in men with erectile dysfunction treated with two regimens of tadalafil: results of the SURE study. [2007.01]
Tadalafil dosed once a day in men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US. [2007.01]
The phosphodiesterase-5 inhibitor tadalafil reduces myocardial infarct size. [2007.01]
Tadalafil is efficacious in Black American and Hispanic men with erectile dysfunction: results from multiple observations in men with erectile dysfunction in national tadalafil study in the US (MOMENTUS). [2007.01]
|
